Category Archives: new treatments
The delta opioid receptor as a novel therapeutic target for the treatment of migraine.
Of interest as delta OR is also involved in anxiolysis. OASIS.
Outcomes from a US military neurology and traumatic brain injury telemedicine program
Articles Outcomes from a US military neurology and traumatic brain injury telemedicine program Ilana R. Yurkiewicz, BS, Charles M. Lappan, MPA, MBA, Edward T. Neely, MD, Roger R. Hesselbrock, MD, Philip D. Girard, MS, Aimee L. Alphonso, BS and Jack … Continue reading
Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults
Good news. Time to start a proper curcumin trial. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults Yen Ying Lim, MPsych, Kathryn A. Ellis, PhD, Robert H. Pietrzak, PhD, MPH, David Ames, MD, … Continue reading
Anti-inflammatory utility of Boswellia serrata (frankincense)
Reading up on Boswellia serrata – this is a good starter article: http://www.altmedrev.com/publications/13/2/165.pdf “Boswellia serrata Description Boswellia serrata (frankincense) is a moderate-to-large branching tree (growing to a height of 12 feet) found in India, Northern Africa, and the Middle East. … Continue reading
Maurice Preter, MD
Maurice Preter, MD is a European and U.S. educated psychiatrist, psychotherapist, psychopharmacologist, neurologist, and medical-legal expert in private practice in Manhattan. He is also the principal of Fifth Avenue Concierge Medicine, PLLC, a medical concierge service and health advisory for select individuals and families.